Quarterly report pursuant to Section 13 or 15(d)

Accrued Expenses

v3.21.2
Accrued Expenses
9 Months Ended
Sep. 30, 2021
Payables And Accruals [Abstract]  
Accrued Expenses

8. Accrued Expenses

Accrued expenses consisted of the following as of September 30, 2021 and December 31, 2020 (in thousands):

 

 

 

September 30, 2021

 

 

December 31, 2020

 

External research and preclinical development

 

$

7,190

 

 

$

4,702

 

Employee compensation and benefits

 

 

3,896

 

 

 

5,715

 

Professional fees

 

 

683

 

 

 

602

 

Facilities and other

 

 

70

 

 

 

65

 

Accrued expenses

 

$

11,839

 

 

$

11,084